AiCuris receives Orphan Drug Designation for its innovative phase II drug AIC246 for the prevention of HCMV disease

AiCuris announced today that AIC246, the Company-s inhibitor against the human cytomegalovirus HCMV, currently undergoing phase IIb testing, has been granted Orphan Drug designation for the prevention of HCMV disease. This decision was made by the European Commission following the positive opinion released by the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA).
"We are very pleased to have received Orphan Drug status for AIC246. This decision b

Collection report autumn/winter 2011/2012

An attractive new style has been added to Felina-s astoundingly successful NOS range Passion from the last autumn/winter season. A high-quality, bi-elastic material and elaborate voile embroidery make the range feel sensational on the skin, while an elegant matte-shine contrast creates a breathtaking look.
To kick off sales in May 2011 Felina will be adding a further attractive bra to the well-established Passion range. The moulded underwired bra was crafted out of a lightweight spacer